Our Technology

a group of plastic cups sitting on top of a machine

Celvion Labs is unlocking regenerative medicine at scale to tackle the root causes of degenerative and inflammatory diseases that currently have no real cure.

Celvion Labs tackle industrialization challenges from the start, making RNA-enhanced exosomes.

To unlock RNA-enhanced exosomes potential, Celvion Labs developed a technology platform based on:

Single cell line sourcing
Proprietary manufacturing technology
Exclusive exosomes loading system

an abstract painting with blue, orange and yellow colors

man in blue scrub suit standing near white and black office rolling chair

person holding orange and white toothbrush

Cell Sourcing

therapeutic exosomes are secreted from our proprietary hTert-immortalized Wharton’s jelly mesenchymal stem cells. This cell line combines the regenerative potency of primary MSCs with the scalability and consistency required for clinical-grade exosome manufacturing. It forms the foundation of a reliable, high-yield, and reproducible exosomes production platform built for therapeutic development.

Manufacturing

Engineering

Proprietary perfused bioreactors enable industrial-scale production at costs 40x cheaper than competitors. This overcomes the common scaling challenges in regenerative medicine.

Our microfluidic-based loading technology is based on a temporary mechanical porosity of the exosomes for payload absorption (mechanoporation). This process enables the loading of cargo, such as RNA, into exosomes without altering their natural therapeutic properties, boosting efficacy while preserving their integrity. Competing methods often compromise exosome quality or increase rejection risk.

Groundbreaking exosome research

Harnessing the power of our Extracellular Vesicles (EVs) technology platform, Celvion Labs has dedicated years to exploring the vast potential of exosomes in natural product development. We concentrate on authentic, fully active exosomes, ensuring they are free from chemicals and additives and preserving their integrity for maximum efficacy.

Our research team is investigating the potential for topical applications of exosomes following cosmetic procedures. We focus on leveraging the naturally occurring properties of exosomes to enhance the appearance of skin and hair, contributing to ongoing advancements in cosmetic science

State of art manufacturing

Celvion Labs produces premium exosomes using advanced, scalable manufacturing platforms and rigorous quality controls. From cell selection to purification and release testing, our process is designed to deliver consistent bioactivity, high purity, and reliable performance.

Advancing the Future of RNA-Enhanced Exosomes Therapeutics

Celvion Labs is a biotechnology company focused on unlocking the power of RNA-enhanced exosomes. Founded in 2025 by experts in cell therapy, biologics, and advanced manufacturing, the company is building a scalable platform that makes next-generation treatments more accessible, more consistent, and more affordable. Celvion Labs revolutionizing large-scale production of RNA-enhanced exosomes by combining cutting-edge manufacturing technology with advanced exosome enrichment systems.

Using its proprietary technology platform, Celvion Labs is developing an exclusive therapeutic portfolio to address osteoarthritis and dermatological conditions.
Through strategic partnerships, Celvion Labs is also expanding its focus to tackle anti aging, cell regeneration, chronic inflammatory, gut, kidney, and neuro-related diseases.
‍
The mission is simple: bring meaningful exosomes innovation to consumers worldwide.